Peer Reviewed
Perspectives

Nonalcoholic fatty liver: an independent predictor of heart disease?

Tissa A Tandiari, Andrew Wilson, Martin Weltman
Abstract
According to recent emerging data, nonalcoholic fatty liver disease has been suggested to be a predictor of heart disease independent of the metabolic syndrome and traditional cardiovascular risk factors.
Key Points
  • Nonalcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease.
  • NAFLD is the hepatic representation of the metabolic syndrome.
  • Ischaemic heart disease (IHD) is the main cause of mortality among patients with NAFLD, and there is a higher prevalence of IHD in patients with NAFLD than in those without the disorder.
  • Statin therapy is generally safe in patients with NAFLD.
  • GPs have a key role in the diagnosis and management of patients with NAFLD.
Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?